US2014275545A1PendingUtilityA1

8-carboxamido-2,6-methano-3-benzazocines

Assignee: RENSSELAER POLYTECH INSTPriority: Oct 31, 2000Filed: Dec 19, 2013Published: Sep 18, 2014
Est. expiryOct 31, 2020(expired)· nominal 20-yr term from priority
A61P 43/00A61P 9/10A61P 37/06A61P 25/28A61P 25/32A61P 25/08A61P 29/00A61P 25/36A61P 25/04A61P 25/30A61P 25/34A61P 3/00A61P 3/04A61P 25/00A61P 25/14A61P 25/02A61P 1/00A61P 13/02A61P 11/00A61P 17/04A61P 1/12A61P 1/06A61P 11/14C07D 489/10C07D 489/00C07D 491/18C07D 489/02C07D 489/08C07D 221/22C07D 489/12A61K 31/485C07D 401/04C07D 221/26C07D 405/06
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

8-Substituted-2,6-methano-3-benzazocines of general structure I in which A is —CH 2 —OH, —CH 2 NH 2 , —NHSO 2 CH 3 , and Y is O, S or NOH are useful as analgesics, anti-diarrheal agents, anticonvulsants, antitussives and anti-addiction medications. 8-Carboxamides, thiocarboxamides, hydroxyamidines and formamides are preferred.

Claims

exact text as granted — not AI-modified
1 . A compound of formula: 
       
         
           
           
               
               
           
         
       
       wherein
 A is chosen from 
 
       
         
           
           
               
               
           
         
         Q is chosen from O, S and NR 17 ; 
         Y is chosen from O, S, NR 17  and NOH; 
         R 1  is chosen from hydrogen, lower alkoxy, phenyl and —NHR 8 ; 
         R 2  and R 2a  are both hydrogen or taken together R 2  and R 2a  are ═O; 
         R 3  is chosen from hydrogen, lower alkyl, alkenyl, aryl, heterocyclyl, benzyl and hydroxyalkyl; 
         R 4  is chosen from hydrogen, hydroxy, amino, lower alkoxy, C 1 -C 20  alkyl and C 1 -C 20  alkyl substituted with hydroxy or carbonyl; 
         R 5  is lower alkyl; 
         R 6  is lower alkyl; 
         R 7  is chosen from hydrogen and hydroxy; or together R 4 , R 5 , R 6  and R 7  may form from one to three rings, said rings having optional additional substitution; 
         R 8  is chosen from hydrogen, —OH, —NH 2  and —CH 2 R 15 ; 
         R 15  is chosen from hydrogen, alkyl, aryl, substituted aryl and alkyl substituted with alkoxy, amino, alkylamino or dialkylamino; 
         R 16  is chosen from hydrogen and NH 2 ; and 
         R 17  is chosen from hydrogen, alkyl, aryl and benzyl. 
       
     
     
         2 . A compound according to  claim 1  wherein A is chosen from the group consisting of: —COOCH 3 , —COOEt, —CONH 2 , —C(═S)NH 2 , —C(O)NHOH, —C(O)NHNH 2 , —CONHCH 3 , —CONHBn, —CONHCH 2 (4-MeOC 6 H 4 ), C(═NOH)NH 2 , C(═NOH)C 6 H 5 , —NHCHO and —NHCHS. 
     
     
         3 . A compound according to  claim 1  selected from: 
       
         
           
           
               
               
           
         
         wherein R 17  is selected from —CH 2 -c-C 3 H 5 , —CH 2 CH═CH 2 , —CH 2 CH═C(CH 3 ) 2 ,  - CH 3 ; 
       
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
       
     
     
         4 . A method of treating a disease or condition selected from pain, pruritus, diarrhea, cough, drug addiction, hyperalgesia, respiratory depression, dyskinesia, gastrointestinal motility disorders, and irritable bowel syndrome comprising the step of administering to a subject in need thereof a compound of formula: 
       
         
           
           
               
               
           
         
       
       wherein
 A is chosen from 
 
       
         
           
           
               
               
           
         
         Q is chosen from O, S and NR 17 ; 
         Y is chosen from O, S, NR 17  and NOH; 
         Z is chosen from OH, SH, CN and NH 2 ; 
         R 1  is chosen from hydrogen, lower alkoxy, phenyl and —NHR 8 ; 
         R 2  and R 2a  are both hydrogen or taken together R 2  and R 2a  are ═O; 
         R 3  is chosen from hydrogen, lower alkyl, alkenyl, aryl, heterocyclyl, benzyl and hydroxyalkyl; 
         R 4  is chosen from hydrogen, hydroxy, amino, lower alkoxy, C 1 -C 20  alkyl and C 1 -C 20  alkyl substituted with hydroxy or carbonyl; 
         R 5  is lower alkyl; 
         R 6  is lower alkyl; 
         R 7  is chosen from hydrogen and hydroxy; or together R 4 , R 5 , R 6  and R 7  may form from one to three rings, said rings having optional additional substitution; 
         R 8  is chosen from hydrogen, —OH, —NH 2  and —CH 2 R 15 ; 
         R 15  is chosen from hydrogen, alkyl, aryl, substituted aryl and alkyl substituted with alkoxy, amino, alkylamino or dialkylamino; 
         R 16  is chosen from hydrogen and NH 2 ; and 
         R 17  is chosen from hydrogen, alkyl, aryl and benzyl. 
       
     
     
         5 . The method according to  claim 4  wherein A is chosen from the group consisting of: —COOCH 3 , —COOEt, —CONH 2 , —C(═S)NH 2 , —C(O)NHOH, —C(O)NHNH 2 , —CONHCH 3 , —CONHBn, —CONHCH 2 (4-MeOC 6 H 4 ), —C(═NOH)NH 2 , -C(=NOH)C 6 H 5 , —NHCHO and -NHCHS. 
     
     
         6 . The method according to  claim 4  wherein said compound is selected from: 
       
         
           
           
               
               
           
         
         wherein R 17  is selected from —CH 2 -c-C 3 H 5 , —CH 2 CH═CH 2 , —CH 2 CH═C(CH 3 ) 2 , —CH 3 ;

Join the waitlist — get patent alerts

Track US2014275545A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.